Jeffrey Wong
Overview
Explore the profile of Jeffrey Wong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iverson T, Alfares H, Nijjar G, Wong J, Abbasi E, Esfandiari E, et al.
PLOS Glob Public Health
. 2024 Dec;
4(12):e0004071.
PMID: 39739729
Social prescribing is a model of care, usually in the community-setting, which aims to address people's unmet social needs. Volunteers support primary health care and community-based care in non-medical roles....
2.
Simiele E, Dandapani S, Han C, Wong J, Hiniker S, Kovalchuk N
Semin Radiat Oncol
. 2024 Dec;
35(1):67-86.
PMID: 39672644
Total body irradiation (TBI) has been an important component of myeloablative and nonmyeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation (HSCT) for decades. Playing a dual role, both cytotoxic...
3.
Koontz B, Koritzinsky M, Zoberi J, Brown S, Ding X, Wong J, et al.
J Appl Clin Med Phys
. 2024 Oct;
25(11):e14533.
PMID: 39447139
No abstract available.
4.
Ladbury C, Hao C, Watkins W, Sampath S, Wong J, Amini A, et al.
Front Immunol
. 2024 Oct;
15:1419788.
PMID: 39411711
Purpose/objectives: Bridging radiation therapy (bRT) is increasingly being utilized prior to chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL). It is unknown how the extent of cytoreduction...
5.
Semwal H, Ladbury C, Sabbagh A, Mohamad O, Tilki D, Amini A, et al.
Prostate
. 2024 Oct;
85(1):3-12.
PMID: 39400372
Background: Though several nomograms exist, machine learning (ML) approaches might improve prediction of pathologic stage in patients with prostate cancer. To develop ML models to predict pathologic stage that outperform...
6.
Davis R, Ladbury C, Tsai K, Maraghechi B, Shi C, Li R, et al.
Cureus
. 2024 Sep;
16(8):e67318.
PMID: 39301330
Trimodality treatment for bladder cancer, consisting of maximal transurethral resection of the tumor followed by concurrent chemoradiotherapy, is an attractive management option with curative and organ-sparing intent. However, such treatment...
7.
Milgrom S, Dandapani S, Wong J, Kalapurakal J, Smith K, Han C, et al.
Pediatr Blood Cancer
. 2024 Aug;
71(11):e31185.
PMID: 39118225
Historically, total body irradiation (TBI) has been delivered using static, parallel opposed photon beams (2D-TBI). Recently, centers have increasingly used intensity-modulated radiation therapy (IMRT) techniques for TBI. Relative to 2D-TBI,...
8.
Zain J, Tsai N, Palmer J, Simpson J, Adhikarla V, Bading J, et al.
Blood Adv
. 2024 Jun;
8(18):4812-4822.
PMID: 38838232
Peripheral T-cell lymphomas (PTCLs) have a poor prognosis with current treatments. High-dose chemotherapy followed by autologous hematopoietic cell transplant (AHCT) is used as a consolidation strategy after achieving clinical remission...
9.
Zheng D, Grandgenett P, Zhang Q, Baine M, Shi Y, Du Q, et al.
Sci Rep
. 2024 May;
14(1):12316.
PMID: 38811597
Addressing the significant level of variability exhibited by pancreatic cancer necessitates the adoption of a systems biology approach that integrates molecular data, biological properties of the tumors, medical images, and...
10.
Potter D, Diep J, Munro C, Lin N, Xu R, Wong J, et al.
BMC Nephrol
. 2024 Apr;
25(1):131.
PMID: 38609846
Background: It is known that COVID-19 disproportionally adversely affects the immunocompromised, including kidney transplant recipients (KTR), as compared to the general population. Risk factors for adverse outcomes and vaccine seroconversion...